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a b s t r a c t
EHD proteins have been implicated in intracellular trafﬁcking, especially endocytic recycling, where they
mediate receptor and lipid recycling back to the plasma membrane. Additionally, EHDs help regulate
cytoskeletal reorganization and induce tubule formation. It was previously shown that EHD proteins bind
directly to the C2 domains in myoferlin, a protein that regulates myoblast fusion. Loss of myoferlin
impairs normal myoblast fusion leading to smaller muscles in vivo but the intracellular pathways
perturbed by loss of myoferlin function are not well known. We now characterized muscle development
in EHD1-null mice. EHD1-null myoblasts display defective receptor recycling and mislocalization of key
muscle proteins, including caveolin-3 and Fer1L5, a related ferlin protein homologous to myoferlin.
Additionally, EHD1-null myoblast fusion is reduced. We found that loss of EHD1 leads to smaller muscles
and myoﬁbers in vivo. In wildtype skeletal muscle EHD1 localizes to the transverse tubule (T-tubule), and
loss of EHD1 results in overgrowth of T-tubules with excess vesicle accumulation in skeletal muscle. We
provide evidence that tubule formation in myoblasts relies on a functional EHD1 ATPase domain.
Moreover, we extended our studies to show EHD1 regulates BIN1 induced tubule formation. These data,
taken together and with the known interaction between EHD and ferlin proteins, suggests that the EHD
proteins coordinate growth and development likely through mediating vesicle recycling and the ability
to reorganize the cytoskeleton.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Skeletal muscle is a complex tissue with inherent renewal
properties that allow for ongoing repair and regeneration. The
elongated nature of individual muscle cells, coupled with their
functional role of contraction, renders muscle highly dependent on
having a rapid and effective vesicle trafﬁcking system for effective
growth and repair (Grounds and Shavlakadze, 2011). Endocytic
recycling, the internalization of membrane and membrane-
associated proteins into the endosomal system and the return of
sorted proteins back to the cell surface is essential for many
cellular functions, including cell migration, cell division, and the
regulation of signaling. Additionally, the ability to coordinate actin
dynamics facilitating cytoskeletal rearrangements near the sarco-
lemma is also critical during myogenesis. Genes encoding proteins
found in these vesicles, which also participate in trafﬁcking path-
ways include caveolin-3, dynamin-2, Bin-1, Bin-3, and dysferlin.
Loss-of-function mutations in many of these genes cause inherited
myopathies including Limb Girdle Muscular Dystrophy (LGMD)
and centronuclear myopathy (Bashir et al., 1998; McNally et al.,
1998; Simionescu-Bankston et al., 2013).
The Eps15 homology-domain containing (EHD) family of pro-
teins has been implicated in the regulation of multiple steps of
endocytic recycling through binding partners such as caveolin-1
and BIN-1 (Grant and Caplan, 2008; Pant et al., 2009; Verma et al.,
2010). Four highly homologous EHD proteins (EHD1-4) are
expressed in mammals and are characterized by an amino-
terminal ATPase domain thought to be required for the scission
of vesicular membranes, a central coiled-coil region, and a single
carboxyl-terminal Eps15 homology (EH) domain (Daumke et al.,
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2007; Mintz et al., 1999). The EH domain of EHD proteins binds
proteins at an Asn-Pro-Phe (NPF) motif (de Beer et al., 1998). The
founding member of the EHD family, the Caenorhabditis elegans
RME-1 (Receptor-Mediated Endocytosis-1) protein, was identiﬁed
in a genetic screen for mutants defective in endocytosis (Grant
et al., 2001). Introduction of each human EHD protein in C. elegans
rme-1 mutants rescued the recycling defect, demonstrating func-
tional similarity between human and C. elegans EHD proteins
(George et al., 2007). However, in mammals, the tissue-speciﬁc
expression, non-complementation results, and distinct pheno-
types from individual EHD gene deletions in mice are all consis-
tent with non-redundant roles of individual mammalian EHD
family members. Overexpression of EHD1 without the EH domain
(EHD1ΔEH) in vitro did not rescue recycling and instead resulted
in perinuclear transferrin accumulation (George et al., 2007).
Ferlin proteins bind EHD proteins directly, and disruption of ferlin
proteins also produces endocytic recycling defects (Doherty et al.,
2008; Posey et al., 2011b).
There is additional support for the role of EHD proteins as
regulators of vesicles sorting at critical nodes from the early
endosome (EE) to the lysosome for degradation or to the endocytic
recycling compartment (ERC) for recycling (Grant and Caplan,
2008). The cargo of these vesicles varies, but has been documented
to include cell signaling receptors like insulin-like growth factor
1 receptor (IGF1R), and the glucose transporter GLUT4, both
important for muscle growth (Guilherme et al., 2004; Naslavsky
and Caplan, 2011; Rotem-Yehudar et al., 2001). EHD interacting
proteins have been identiﬁed, which regulate the trafﬁcking and
recycling of cell-surface signaling receptors and/or rearrangement
of the actin cytoskeleton (Braun et al., 2005; Grant and Caplan,
2008; Guilherme et al., 2004). Examples of EHD interacting
proteins include vesicle membrane components like clathrin
heavy chain and cytoskeletal rearrangement proteins like actin
binding proteins EHBP1 and MICAL-L1 (Guilherme et al., 2004;
Sharma et al., 2009). Ferlin proteins bind EHD proteins directly
(Doherty et al., 2008; Posey et al., 2011b). The ferlin family
members contain multiple C2 domains, and the second C2
domain, (C2B), of myoferlin contains an NPF motif that binds
EHD1 and EHD2 (Doherty et al., 2008; Posey et al., 2011b). The
related ferlin protein, Fer1L5, also contains an NPF motif in its
second C2 domain and this region also directly binds to both EHD1
and EHD2 (Posey et al., 2011b).
EHD1-null mice display signiﬁcant embryonic lethality but
surviving mice exhibit reduced growth compared to wildtype
mice; EHD1-null males are infertile due to defective spermatogen-
esis (Rainey et al., 2010). In another model of EHD1-deﬁciency,
mouse embryonic ﬁbroblasts from EHD1-null mice exhibited
impaired transferrin recycling consistent with the role of EHDs
in recycling (Rapaport et al., 2006). Analysis of EHD protein
expression has shown a role for EHD2 in membrane repair and
revealed that EHD3 and EHD4 were both highly upregulated after
myocardial infarction in wildtype mice, suggesting a role for EHD
proteins in damage response in both skeletal and cardiac muscle
(Gudmundsson et al., 2010; Marg et al., 2012). In addition, the EHD
proteins have been shown to directly associate with ankyrin, a
protein required for membrane targeting and stability of ion
channels, cell adhesion molecules, and signaling proteins, in
cardiomyocytes (Gudmundsson et al., 2010).
We analyzed mice lacking EHD1 to investigate the in vivo
role of EHD1 in muscle growth and development. Consistent with
a recycling defect, myoblasts cultured from EHD1-null mice
accumulate more intracellular transferrin than wildtype primary
myoblasts. In addition, EHD1-null myoblasts have mislocalized
caveolin-3 and Fer1L5 and are defective in the formation of large
myotubes in vitro. EHD1-null skeletal muscle was found to lack
the largest myoﬁbers and have reduced muscle mass. We show
tubule formation requires a functional ATPase domain of EHD1
and EHD1 regulates BIN1 induced tubule formation. These data
extend the vesicle trafﬁcking complex in muscle to include EHD1.
The abnormal T-tubule structure seen in EHD1-null muscle sup-
ports that ferlin-EHD mediated vesicle trafﬁcking regulates the
biogenesis and maintenance of T-tubules, and this formation is
essential for muscle growth.
Materials and methods
Animals
EHD1-null mice were previously generated by deleting exon 1
(Rainey et al., 2010). Heterozygous mice were interbred to gen-
erate EHD1-null mice. Mice were housed in speciﬁc pathogen free
facility in accordance with the University of Chicago Institutional
Animal Care and Use Committee regulations. Consistent with what
was reported, less than 5% of EHD1 mice survived postnatally.
Muscle analysis
Muscles were examined from mice surviving until ten weeks of
age. The quadriceps femoris and triceps brachii muscles were
dissected from tendon to tendon from ten-week old male mice.
The excised muscle was preserved in 10% formalin, bisected in the
mid-belly, and embedded in parafﬁn. Sections from the center of
the muscle were stained with hematoxylin and eosin. Images of
entire muscle sections were taken at 1.5 and composite muscle
sections were reconstructed using overlapping 10 images. Using
ImageJ, the total number of ﬁbers, mean ﬁber size, and total
muscle area for both triceps and quadriceps muscles were ana-
lyzed. The mean ﬁber size was calculated from the area of 618
wildtype and 677 EHD1-null ﬁbers (200 ﬁbers per animal, n¼3
animals per genotype). Statistics were performed with Prism
(Graphpad, La Jolla, CA) using an unpaired t-test.
Muscle preparation and immunostaining
Quadriceps muscles from wildtype and EHD1-null mice were
dissected and frozen in liquid nitrogen-cooled isopentane and cut
in 7 mm sections that were ﬁxed in paraformaldehyde, blocked in
1 phosphate-buffered saline (PBS) containing 10% fetal bovine
serum, and immunostained. Isolated myoﬁbers were isolated from
the ﬂexor digitorum brevis (FDB). Muscle was removed and
incubated in collagenase II (Invitrogen, 17101-015). After 2–3 h,
FDB bundles were moved to media containing 3% bovine serum
albumin and 0.1% gentamicin for trituration. Free ﬁbers were
incubated at 37 degrees overnight and plated on matrigel (BD
Bioscience, 356234) coated coverslips. Fibers were ﬁxed in 4% PFA,
rinsed, and blocked in Super Block (Pierce, 37515) with 0.1% triton.
Rabbit polyclonal anti-Fer1L5 antibody (Posey et al., 2011b) was
used at 1:100, anti-caveolin3 (BD Transduction, 610420, Franklin
Lakes, NJ) was used at 1:100, anti-BIN1 (Santa Cruz, sc-23918,
Santa Cruz, CA) was used at 1:100, anti-DHPR (Pierce, MA3-920)
was used at 1:100, and rabbit polyclonal anti-EHD1 (Rainey et al.,
2010) was used at 1:100. Secondary antibodies goat anti-rabbit
Alexa 488 antibody (Invitrogen, A11008, Eugene, OR) was used at
1:2500–1:5000, goat anti-mouse Alexa 594 (Invitrogen, A11005,
Eugene, OR) was used at 1:2500–1:5000. Images were captured
using a Zeiss Axiophot microscope and Axiovision software (Carl
Zeiss, Maple Grove, MN). Single slice confocal images were
captured on a Leica SP2 confocal or a Leica SP5 superresolution
laser scanning confocal microscope.
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Expression of wild type and T72A EHD1
The full-length EHD1 cDNA was ampliﬁed from the pSport
EHD1 vector (Addgene) and ligated into the EcoR1 site of pcDNA3-
mcherry. The T72A mutation was generated by site directed
mutagenesis using the following primers: (A) GGGTA-
CCATGTTCAGCTGGGTGAGCAAGG (B) GCACCGGCAAGGCCACCTT-
CATCCG (C) GCCGAAGGCGTTGAGCTTGCGGAAGG (D) CGGATGAA
GGTGGCCTTGCCGGTGC. pEGFPC1-muscle Amphiphsin II (BIN1
variant 8) was purchased from Addgene. C2C12 cells were plated
at 50,000 cells per well on glass coverslips in 6-well plates. Cells
were cotransfected with equal amounts of BIN1, EHD1 and T72A
EHD1 plasmid or in combination using Lipofectamine and Plus
Reagent in Opti-MEM (Invitrogen). Twenty-four hours post trans-
fection, cells were ﬁxed, mounted in Vectashield with DAPI and
imaged. Images were acquired on the Leica SP5 II STED-CW
superresolution laser scanning confocal microscope. To analyze
BIN1 tubule formation, a 20 mm2 area extending from the peri-
nuclear region to cell periphery was selected. A custom script was
written and run in Image J. Brieﬂy, ﬂuorescent images were
processed with a rolling ball ﬁlter. A threshold was applied to
the ﬁltered images to generate binary images, which were then
skeletonized similar to (Beraud et al., 2009).
Tubules were deﬁned as individual line segments in the
skeletonized images. The number and length tubules were deter-
mined in each image. n41000 Tubules from at least 5 cells per
transfection condition.
Electron microscopy
Quadriceps muscles from 2-month old wildtype and EHD1-null
mice were dissected and placed in 4% paraformaldehyde. The
tissue was postﬁxed in 1% OsO4, rinsed, and processed for Epon
embedding. Embedded samples were sectioned and stained with
1% uranyl acetate followed by lead citrate. Semithin (0.5 mm)
toluidine blue stained sections were used to pre-screen the tissue
and select areas for subsequent thin sectioning and electron
microscopy (Philips CM10).
Isolation and culture of primary myoblasts
Primary myoblast cultures were isolated from embryos taken
17 days post fertilization (dpf) and cultured as described
(Demonbreun et al., 2010; Rando and Blau, 1994). Brieﬂy, cells
were plated in primary cell growth media (Ham0s F-10 with 20%
fetal bovine serum and bFGF 2.5 ng/ml (Promega) with 1%
antibiotic-antimycotic (Invitrogen, 15240-062) and 1% penicillin/
streptomycin (Invitrogen, 15070-063). Two hundred thousand
cells per well were plated on ECL-treated NaOH treated coverslips
in 6-well plates. Cells were induced to differentiate through serum
withdrawal. After 72 h, cells were ﬁxed with PFA and stained with
anti-desmin and visualized using a Zeiss Axiophot microscope and
Ivision software. At least four random images were taken per
culture each at an equivalent cell density. The number of nuclei
per desmin positive cell was counted, binned, and an un-paired t-
test was performed using Prism Graphpad.
Vesicle analysis and immunostaining
Primary myoblasts were isolated as above and plated at equal
densities on NaOH-washed glass coverslips within 6-well plates at
200,000 cells per well. Cells were ﬁxed in 4% paraformaldehyde
for 10 min. Blocking and antibody incubations were performed in
1 phosphate-buffered saline (PBS) containing 5% fetal bovine
serum. Rat polyclonal anti-lysosomal associated membrane pro-
tein (LAMP)-2 antibody (Abcam, ab13524) was used at 1:600 and
goat anti-rat conjugated to Alexa 488 was used at 1:2000. Cover-
slips were mounted using Vectashield with DAPI (Vector Labora-
tories, Burlingame, CA). Images were captured using a Zeiss
Axiophot microscope and Axiovision software (Carl Zeiss, Maple
Grove, MN). ImageJ particle analysis software was used to analyze
particle number and statistical analysis was performed with Prism
(Graphpad) using an unpaired t-test.
Immunoblotting
Wildtype and EHD1-null quadriceps muscles were homoge-
nized and 20 mg of protein was separated on a 4–12% gel (Life
Technologies). Protein was transferred to PDVF membrane and
blocked with T-20 Starting Block (Pierce). Mouse polyclonal anti-
Rab5 was used at 1:250 (BD Transduction Laboratories, 610281)
and mouse anti Rab-11 was used at 1:250 (BD Transduction
Laboratories, 610656). Secondary goat anti-mouse HRP was used
at 1:2500. Images were acquired on a Bio Spectrum Imaging
System (UVP) and processed in Adobe Photoshop.
Transferrin internalization and chase assay
Primary myoblasts were seeded in 6-well plates at 200,000
cells per well. Cells were incubated in binding media (DMEM, 0.1%
BSA, 20 mM HEPES, pH 7.2) for 30 min and then pulsed with
Alexa-546 conjugated transferrin (25 μg/ml, Molecular Probes) in
binding media for 15 min. Cells were liberated from wells with
trypsin for 1 min, washed in 1 PBS, and then ﬁxed in 4%
paraformaldehyde for 10 min. For chase assay, cells isolated and
pulsed as described above, then were chased for 0, 20, or 40 min
with 50 mM deferoxamine, 250 μg/ml of holo-transferrin in 20%
FBS, 20 mM HEPES, pH 7.2. For both assays, cells were resuspended
in PBS for analysis in a FACS Aria (BD Biosciences). After gating to
remove dead cells, aggregated cells and debris, a minimum of
10,000 events was scored per culture. Cultures were derived from
three independent animals per genotype for the internalization
assay and at least two independent animals per genotype for the
chase assay. Median ﬂuorescence values were determined using a
histogram of Alexa-546 ﬂuorescence and normalized to wildtype
cultures. FACS data was analyzed using FlowJo software (Tree Star,
Inc). Statistical analysis was performed using Prism (Graphpad)
using an unpaired t-test.
Results
Defective endosomal trafﬁcking in EHD1-null myoblasts
EHD proteins as well as several ferlin family members have
previously been implicated in endosomal trafﬁcking (Austin et al.,
2010; Demonbreun et al., 2011, 2010; Naslavsky et al., 2007;
Rotem-Yehudar et al., 2001). To determine whether endocytic
recycling was altered in myoblasts, we studied EHD1-null myo-
blasts using the transferrin assay (Demonbreun et al., 2011;
Doherty et al., 2008). Labeled transferrin is endocytosed to the
recycling compartment and then recycled from the cell within
minutes. Primary myoblasts isolated fromwildtype and EHD1-null
embryos were incubated for 15 min with transferrin conjugated to
Alexa-546. We then analyzed the pulsed myoblasts for ﬂuorescent
intensity and demonstrated that EHD1-null primary myoblast
cultures consistently had more mean ﬂuorescent intensity than
wildtype myoblast cultures as shown by the rightward shift in the
scatter plots in the EHD1-null graph (Fig. 1A, right). When
quantiﬁed, this difference was statistically signiﬁcant (po0.001)
(Fig. 1B). To determine if this increase was due to enhanced uptake
of transferrin or delayed recycling, we pulsed the myoblasts for
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15 min as described above, chased the cultures for 0, 20 or 40 min
with unlabelled transferrin, and then analyzed the ﬂuorescent
intensity of the individual myoblasts. After 0, 20, and 40 min of chase,
a greater number of EHD1-null myoblasts displayed transferrin
ﬂuorescence (p¼0.02, p¼0.03 and p¼0.08 respectively) compared
to wildtype controls, conﬁrming a defect in EHD1-null myoblast
recycling (Fig. 1C). Speciﬁcally, after 20 min of chase, 2.3-fold more
EHD1-null myoblasts retained labeled transferrin than wildtype
myoblasts very similar to the 3.3-fold increase in EHD1-null ﬁbro-
blasts reported by Rapaport et al. (2006). The endocytic recycling
defect of EHD1-null myoblasts was visualized further as an increased
number of LAMP2þ vesicles was present within EHD1-null myo-
blasts (Fig. 1D and E) (p¼0.002). To assess further the defects in the
endocytic recycling pathway, immunblotting for Rab5 and Rab11 was
performed. Rab5 and Rab11 are proteins known to regulate endocytic
recycling from the plasma membrane to the endocytic recycling
compartment and from the endocytic recycling compartment to
the plasma membrane, respectively. EHD1-null skeletal muscle
expressed similar amounts of Rab5 protein as WT muscle. However,
EHD1-null muscle had increased levels of Rab11 protein. These data
suggest that changes in the Rab proteins are not the cause of the
defects in transferrin accumulation but rather Rab 11 is upregulated
in response to the loss of EHD1 likely to compensate for the
accumulation at the endocytic recycling compartment. Together
these data demonstrate that EHD1 is involved in endocytic recycling
in muscle, and that muscle like neurons and ﬁbroblasts is dependent
on EHD1 for inﬂuences on the recycling and lysosomal pathways
(Lasiecka et al., 2010; Rapaport et al., 2006).
Fig. 1. Reduced recycling and lysosome accumulation in EHD1-null myoblasts. (A) Wildtype and EHD1-null primary myoblasts were incubated with transferrin conjugated
to Alexa-546 for 15 min and analyzed for ﬂuorescence intensity by FACS. FACS proﬁles showed increased transferrin accumulation in EHD1-null myoblasts. (B) EHD1-null
myoblasts contained approximately 20% more transferrin ﬂuorescence compared to wildtype myoblasts (n¼3 replicates, p¼0.001). (C) Wildtype and EHD1-null primary
myoblasts were pulsed with transferrin conjugated to Alexa-546, chased with unlabelled transferrin for 0, 20, or 40 min and then analyzed by FACS for ﬂuorescence intensity.
A greater number of EHD1-null myoblasts retained Alexa-546 ﬂuorescence at 0, 20, and 40 min consistent with a defect in recycling (npo0.03, þp¼0.08). (D) Lysosomes
were identiﬁed in wildtype and EHD1-null myoblasts using anti-LAMP2 antibody (green). Nuclei are stained with DAPI (blue). Scale bar 10 mm. (E) The number of LAMP2-
positive vesicles was increased in EHD1-null primary myoblasts (mean number 23 in wildtype myoblasts and 38 in EHD1-null myoblasts, n¼13, p¼0.002). (F) Immunoblot
of WT and EHD1-null muscle lysates. WT and EHD1-null muscle show similar Rab5 expression levels. Rab11 expression levels are increased in EHD1-null muscle. Actin is
shown as a loading control.
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EHD1-null myoblasts display abnormal Fer1L5 and caveolin-3
aggregation
We previously showed a direct interaction between Fer1L5 and
EHD1 (Posey et al., 2011b). We immunostained myoblasts from
EHD1-null mice and wildtype littermates with an antibody speciﬁc
for Fer1L5 and also for caveolin-3, a protein also implicated in
muscle vesicle trafﬁcking and muscle disease. In the confocal
images of wildtype myoblasts, Fer1L5 (red) and caveolin-3 (green)
colocalize throughout the myoblast and are seen localized in
discrete tubules (Fig. 2, top panel, dotted arrow). However, in
EHD1-null myoblasts, Fer1L5 and caveolin-3 primarily colocalize
in the perinuclear region (Fig. 2, bottom panel, white arrow). In
EHD1-null myoblasts both Fer1L5 and caveolin-3 were more
diffusely distributed in all cells analyzed, presumably due to the
mislocalization of the proteins. DIC images are shown to outline
the cells. This data suggests that EHD1 is necessary for proper
trafﬁcking and localization of Fer1L5 and caveolin-3 and suggests,
in addition to general recycling defects, ferlin aggregation as a
mechanism for developmental defects in EHD1-null muscle.
Impaired myoblast fusion without EHD1
We next examined whether loss of EHD1 perturbed myoblast
fusion. EHD1-null mice exhibit a signiﬁcant embryonic lethality
(Mate et al., 2012; Rainey et al., 2010). Most EHD1-null mice die
during gestation or shortly after birth (Mate et al., 2012; Rainey
et al., 2010). To avoid this lethality, we utilized viable embryos
(17 dpf) as the source for primary myoblasts. Primary myoblasts
were isolated from wildtype and EHD1-null embryos (2 wildtype
cultures, both performed in duplicate; 3 EHD1-null cultures, one
performed in duplicate, all from independent embryos). Cells were
allowed to differentiate for 72 h via serum withdrawal, ﬁxed, and
then stained with anti-desmin, a myogenic marker. Representative
images are shown in Fig. 2B. The number of nuclei in each desmin
positive cell was counted and binned. Results are expressed
graphically as the percentage of ﬁbers with n number of nuclei
per ﬁber/cell (Fig. 2C). Despite serum withdrawal EHD1-null cells
remained singly-nucleated in over 95% of desmin positive cells,
while wildtype cells had readily formed large multinucleate
myotubes. EHD1-null cells rarely fused into microtubes containing
2–3 nuclei, 3.5%, compared to wildtype cultures 28.8%, and rarely
fused into myotubes containing 4þ nuclei, 1.5%, versus wildtype
28.8%. Increasing the density of desmin positive cells per area
within the culture did not increase the fusion potential of EHD1-
null cultures, but did induce larger myotubes in wildtype cultures
(data not shown). These results suggest that both recycling and
fusion pathways are altered by the loss of EHD1 and ultimately
contribute to muscle growth.
EHD1-null mice have smaller muscles
Surviving EHD1-null mice were previously noted to have
signiﬁcantly reduced body mass compared to wildtype littermates
(Mate et al., 2012; Rainey et al., 2010). Because of the contribution
of muscle mass to overall body mass, we examined muscle in
EHD1-null mice. For these experiments, we used surviving EHD1-
null mice and studied animals at 8–10 weeks of age. Representa-
tive images from wildtype and EHD1-null triceps and quadriceps
muscle cross-sections are shown in Supplemental Fig. 1A and D.
The cross-sectional area (CSA) of whole muscles from EHD1-null
was reduced in both the upper extremities (Supplemental Fig. 1B)
Fig. 2. Loss of EHD1 impairs protein trafﬁcking and fusion in myoblasts. (A) Representative images of wildtype and EHD1-null primary myoblasts immunostained with anti-
Fer1L5 (red), anti-caveolin-3 (green), and DAPI (blue). In normal myoblasts, Fer1L5 colocalized with caveolin-3 throughout the cytoplasm in discrete tubules (top row, dotted
arrow). In EHD1-null myoblasts (bottom row), the majority of Fer1L5 and caveolin-3 were found in the perinuclear region (white arrow) with only minimal diffuse staining
in the cytoplasm (arrowhead). Scale 10 mm. High magniﬁcation images are found to the far right. Scale 5 mm. (B) Wildtype and EHD1-null myoblasts were differentiated and
then stained with an anti-desmin antibody (red). Desmin staining identiﬁes cells that have entered into myogenic differentiation and, in combination with DAPI (blue nuclei)
staining, highlights multinucleate versus single nucleate cells. Scale bar 50 mm. (C) EHD1-null myoblasts fused poorly with very few binucleate or multinucleate myotubes.
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and lower extremities (Supplemental Fig. 1E). In quadriceps
muscle, the EHD1-null CSA was 16.80 mm2 and in WT it was
23.72 mm2, (n¼4 quadriceps from 3 mice, p¼0.007). In the triceps
muscle, the mean CSA was 12.30 mm2 in EHD1-null and
17.54 mm2 in WT (n¼6 triceps from 3 mice, p¼0.004.)
The reduced muscle size in EHD1-null mice derived from both
reduction of myoﬁber number as well as myoﬁber size. EHD1-null
quadriceps muscles contained approximately 20% fewer myoﬁbers
than wildtype littermates. In quadriceps muscle, the EHD1-null
average ﬁber number was 5711 and in WT it was 7121, (n¼3,
p¼0.0072). In triceps muscle, the average ﬁber number was 5095
in EHD1-null and 6193 in WT (n¼4, p¼0.02.) (Supplemental
Fig. 1C and F). Individual myoﬁbers also had reduced CSA in
EHD1-null muscle relative to wildtype littermates (Fig. 3A).
EHD1-null quadriceps myoﬁbers had a mean CSA of 1589 mm2
compared to the mean CSA of wildtype muscle ﬁbers of 2522 mm2,
Fig. 3. Reduced muscle size in EHD1-null muscle. (A) Multiple images of the quadriceps muscles were used to quantify ﬁber size as cross sectional area (CSA). EHD1-null
myoﬁbers had reduced CSA. The mean wildtype ﬁber CSA size was 2522 mm2 while the EHD1-null mean was 1589 mm2 (po0.0001). (B) EHD1-null muscle contained smaller
muscle ﬁbers and speciﬁcally the largest myoﬁbers were absent (black arrows). (C) Representative images from mature wildtype and EHD1-null quadriceps muscle. EHD1-
null myoﬁbers were smaller in cross sectional area and do not display obvious ﬁbrosis as would be seen in muscular dystrophy. Scale bar 50 mm. (D) Electron micrographs of
EHD1-null quadriceps muscle. White arrows depict lysosomal vesicles within EHD1-null muscle. Lysosomes were never seen in wildtype muscle. High magniﬁcation image
(right) shows lysosomes ﬁlled with debris.
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which represents a 37% reduction in mean ﬁber size (n¼at least
two hundred ﬁbers per mouse, three mice per genotype,
po0.0001). We examined the distribution of myoﬁber size in
the quadriceps muscle and found that EHD1-null muscle speciﬁ-
cally lacked the largest myoﬁbers (Fig. 3B, arrows). Myoﬁbers
larger than 3500 mm2 in area contribute nearly a quarter (23.1%) of
wildtype muscle; these ﬁbers only contribute 0.7% of EHD1-null
muscle myoﬁbers.
Lysosomal aggregation in EHD1-null skeletal muscle
Histopathology of EHD1-null muscle showed a largely intact
muscle that was not characterized by ﬁber necrosis, ﬁbrosis, fat,
and immune inﬁltrate, features commonly found in muscular
dystrophy (Fig. 3C). At the ultrastructural level, sarcomere struc-
ture appeared normal. However, lysosomal accumulations were
seen regularly in EHD1-null muscle and were never seen in WT
tissue (Fig. 3D). A higher magniﬁcation electron microscopy image
shows lysosomes containing debris in EHD1-null muscle (Fig. 3D,
right) (Rodriguez et al., 1997). The accumulation of enlarged
lysosomes is similar to what was seen in myoferlin-null skeletal
muscle, suggesting a trafﬁcking defect in EHD1-null muscle
(Demonbreun et al., 2010).
EHD1 localizes to the plasma membrane and T-tubules in healthy,
wildtype skeletal muscle
BIN1 and DHPR are known markers of transverse tubules, a
sarcolemmal invagination specialized for calcium delivery. BIN1
also colocalizes with other important muscle proteins at the
tubule including caveolin-3 and Fer1L1, also known as Dysferlin
(Klinge et al., 2007; Lee et al., 2002). In normal muscle imaged
under high-resolution immunoﬂuorescence microscopy, EHD1
localized to the T-tubule in skeletal muscle. In single slice confocal
images of myoﬁbers, EHD1 localizes partially with the T-tubule
protein DHPR (Fig. 4, DHPR red, EHD1 green, right merge). High
magniﬁcation images are shown on the far right. Additionally, in
single slice confocal images of myoﬁbers, EHD1 localizes partially
with BIN1, an additional T-tubule marker, at T-tubule structures
and at the sarcolemma (Fig. 4B; BIN1 red, EHD1 green, right
merge). High magniﬁcation images are shown on the far right.
Fig. 4. EHD1 localizes to the T-tubule in wildtype muscle. Representative single slice confocal images are shown with high magniﬁcation images on the right. (A) Myoﬁbers
were stained with anti-DHPR (red) and anti-EHD1 (green) antibodies. EHD1 localizes partially with the T-tubule marker, DHPR. (B) Additional myoﬁbers were stained with
anti-BIN1 (red) and anti-EHD1 (green) antibodies. EHD1 staining partially overlaps with BIN1 at the T-tubule and at the sarcolemma within wildtype myoﬁbers. Scale bar
5 mm.
Fig. 5. T-tubule overgrowth in EHD1-null skeletal muscle. Longitudinal sections of wildtype and EHD1-null quadriceps muscle conﬁrm increased anti-BIN1 (red) and anti-
Fer1L5 (green) staining in malformed, elongated T-tubules of EHD1-null muscle compared to regularly shaped punctate tubules in wildtype controls. Scale bar 20 mm.
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The localization of EHD1 to the tubule region suggests a potential
role for EHD1 at the T-tubule.
T-tubular overgrowth in EHD1-null skeletal muscle
EHD1 has been implicated in tubule structure formation
(Caplan et al., 2002). BIN1, also known as Amphiphysin 2, is
involved in vesicle trafﬁcking and in generating tubular invagina-
tions implicated in T-tubule biogenesis, and mutations in BIN1
cause centronuclear myopathy (Nicot et al., 2007; Toussaint et al.,
2007). Fig. 5 shows mature muscle from wildtype (top row) and
EHD1-null (bottom row) muscle with anti-Fer1L5 and anti-BIN1
processed and imaged identically. In longitudinal sections, EHD1-
null myoﬁbers contain elongated T-tubules with high levels of
anti-BIN-1 expression in contrast to punctate structures viewed in
wildtype controls (Fig. 5, left panels). Fer1L5 localization mirrored
what was seen for BIN1 in both the EHD1-null and wildtype
muscle with elongated abnormal T-tubules within the EHD1-null
muscle compared to the small punctate structures found in normal
muscle (Fig. 5, middle panels). Normal muscle rarely showed
colocalization of Fer1L5 and BIN1 in T-tubule puncta, while the
malformed EHD1-null T-tubules showed colocalization in the
majority of T-tubules (Fig. 5, right panels).
Mislocalized caveolin-3 and Fer1L5 in EHD1-null muscle
We next studied the localization of both caveolin-3 and Fer1L5
in mature muscle (ten weeks of age). Immunoﬂuorescence micro-
scopy of wildtype muscle showed anti-Fer1L5 staining primarily
within the ﬁber in small vesicles and tubules (Fig. 6A top row,
green) and caveolin-3 staining localized to the plasma membrane
(Fig. 6A, top row, red). Images of EHD1-null muscle, processed and
imaged identically to the wildtype muscle, showed more intense
staining of both Fer1L5 and caveolin-3 within the myoﬁbers and
caveolin-3 at the sarcolemma (Fig. 6A bottom row, left and
middle). Anti-dystrophin staining (green) is present at the sarco-
lemma in wildtype and EHD1-null myoﬁbers at equal levels,
demonstrating the integrity of both muscle sections despite the
abnormal caveolin-3 membrane localization in the EHD1-null
muscle (Fig. 6B). Confocal imaging of wildtype ﬁbers shows
caveolin-3 was largely conﬁned to the sarcolemma, while Fer1L5
was present at the sarcolemma and internal puncta (Fig. 6C top
row, merge right). In EHD1-null muscle, caveolin-3 was increased
at the sarcolemma (Fig. 6C bottom row, red) and internal caveolin-
3, within the myoﬁber, was found to colocalize with internal
Fer1L5 expression (Fig. 6C bottom row, white arrow, right, merge).
Fer1L5 was found in vesicles or tubular-like structures often
adjacent to caveolin-3-rich areas at the plasma membrane
Fig. 6. Abnormal localization of Fer1L5 and caveolin-3 in mature EHD1-null muscle. Mature muscle was stained with anti-Fer1L5 (green) and anti-caveolin-3 (red)
antibodies. DAPI is shown in blue. (A) Fer1L5 and caveolin-3 internal staining was increased in EHD1-null muscle (bottom row) compared to wildtype controls (top row).
Scale bar 30 mm. (B) Wildtype and EHD1-null muscle were stained with anti-dystrophin (green) and DAPI (blue) to outline the myoﬁbers, conﬁrming the presence of a
uniform sarcolemma in both samples. Scale bar 30 mm. (C) Fer1L5 and caveolin-3 colocalized in EHD1-null muscle at the membrane in vesicular patterns and within the
muscle ﬁber on tubule structures (bottom row; merge, arrow). Scale bar 1 mm. (D) Low magniﬁcation image of an EHD1-null myoﬁber with excessive internal Fer1L5 and
caveolin-3 tubules. Scale bar 10 mm.
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(Fig. 6C bottom row, right, merge). A low magniﬁcation image of
internal tubules enriched in caveolin-3 and Fer1L5 within an
EHD1-null myoﬁber is shown in Fig. 6D.
Ultrastructural overgrowth of T-tubules in the absence of EHD1
To conﬁrm the immunoﬂuorescence data, we analyzed the
sarcotubule network by electron microscopy. At the ultrastructural
level, elongated T-tubules (Fig. 7, white arrowheads) were asso-
ciated with multiple vesicles in the EHD1-null muscle (Fig. 7,
white arrows), distinct from what was seen in normal muscle. The
majority of T-tubules in EHD1-null muscle stretched over 2 mm in
length, approximately 20 times longer than wildtype T-tubules.
A magniﬁed view of an elongated T-tubule surrounded by vesi-
cular structures in EHD-null muscle is depicted in the right panel
of Fig. 7. Additionally, the sarcoplasmic reticulum was dilated in
EHD1-null muscle compared to normal controls (Fig. 7, black
arrow). The abnormal T-tubules and sarcoplasmic reticulum are
consistent with a defect in vesicle trafﬁcking, which results in
profound defects in the sarco-tubule system of mature muscle.
The EHD1 ATPase domain is necessary for EHD1 tubule formation
The EHD proteins are composed of an ATPase domain, a central
coiled-coil region, and the EH domain necessary for many protein-
protein interactions, including the EHD-ferlin interaction. Detailed
structural and residue analysis of EHD1 is lacking. However,
structural analysis of EHD2 is available including information on
several key amino acid residues known to affect the ATPase
domain and protein function (Daumke et al., 2007). The T72A
mutation substitutes an alanine on a residue within the nucleotide
binding P-loop of the ATPase domain and abolishes EHD2 ATPase
activity (Daumke et al., 2007). ATPase activity is thought to be
required for membrane scission of exocytic vesicles from the
endocytic recycling compartment after EHD proteins oligomerize
around the membrane (Daumke et al., 2007). Because EHD1 and
EHD2 are over 70% homologous, and siRNA reduction of
both proteins inhibited myoblast fusion myogenic in C2C12 cells
(Posey et al., 2011b), we generated the T72A mutation within a
carboxy-terminal EHD1-mcherry fusion protein and expressed
it in undifferentiated C2C12 myoblasts. In the presence of endo-
genous EHD1, EHD1-mCherry localized to discrete tubules
throughout the myoblast (Fig. 8A, left). Upon EHD1T72A expres-
sion, EHD1T72A-mCherry was instead dispersed throughout the
cytoplasm and EHD1T72A-mCherry positive tubules were not
formed in C2C12 myoblasts (Fig. 8A, right). A high resolution
image of the boxed area within each myoblast is found in the
lower right of each panel (Fig. 8). The mis-localization of mutant
EHD1 protein to the cytoplasm was reminiscent of what was seen
when EHD2T72A was expressed in other cell types (George et al.,
2007; Moren et al., 2012). Thus, the EHD1 ATPase activity is
necessary for EHD1 tubule formation in myoblasts and tubule
formation may relate to myoblast fusion.
EHD1 regulates BIN1 tubule formation
Previous work established a molecular and functional interac-
tion between EHD and amphiphysin/BIN orthologs RME-1 and
AMPH-1 in C. elegans (Pant et al., 2009). BIN1 is known to be
necessary for the formation of T-tubules in vivo (Lee et al., 2002).
C2C12 cells were transfected with BIN1-GFP, EHD1-mCherry, and/
or EHD1T72A alone or in combination. Twenty-four hours post
transfection tubule formation within cells was monitored. BIN1-
GFP or EHD1-mCherry individually can support the formation of
intracellular tubules in C2C12 myoblasts (Fig. 8A and B). The
combination of EHD1-mCherry and BIN1-GFP generated large,
organized tubules, extending from the perinuclear region to the
periphery in C2C12 myoblasts (Fig. 8C, top row). The combination
of EHD1T72A-mCherry and BIN1-GFP produced tubules that were
smaller (0.51 mm compared to 0.662 mm tubules, p¼0.007), more
numerous (268 compared to 166 tubules per 20 mm2 area, p¼0.04)
and less organized (Fig. 8C, bottom row). Comparison of the high
magniﬁcation insets in Fig. 8C highlights the less organized nature
of the BIN1 tubules induced by EHD1T72A versus EHD1. These data
are consistent with the observed in vivo ectopic tubule formation
seen in EHD1-null muscle and suggest that this defect arises
directly from misregulation of BIN1.
Discussion
Defective recycling in myoblast from loss of EHD1
Mammalian models of loss-of-function mutations for EHD
proteins have only recently become available, and the initial
characterizations have focused on male fertility (George et al.,
2010; Rainey et al., 2010; Rapaport et al., 2006). Although most
EHD1-null mice die during in utero development, approximately
Fig. 7. Enlarged sarcoplasmic reticulum and T-tubular structures in the absence of EHD1. Representative electron microscopy images of swollen sarcoplasmic reticulum
(black arrow), elongated T-tubules (white arrowhead), and vesicular structures (white arrow) juxtapose the T-tubules in EHD1-null quadriceps muscle. This was never seen
in wildtype controls. A magniﬁed view of the EHD1-null disrupted sarco-tubular system is shown in the right panel.
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5–8% survive into adulthood (George et al., 2010; Rainey et al.,
2010). Why some mice survive to adulthood is not known, but the
high conservation between EHD proteins suggests that compensa-
tion by other EHD family members may, in some cases, be
sufﬁcient to allow survival. We now found that EHD1 is critically
important for muscle development, growth and function. We
previously linked EHD proteins to receptor recycling defects in
muscle ﬁnding that myoferlin directly interacts with EHD1 and
EHD2, and that loss of myoferlin leads to abnormal receptor
trafﬁcking (Demonbreun et al., 2010; Doherty et al., 2008; Posey
et al., 2011a, 2011b). IGF is a potent stimulator of prenatal growth.
Normally IGF1 stimulation causes muscle ﬁber hypertrophy and in
developing myoﬁbers (Zanou and Gailly, 2013). Myoferlin-null
mice do not respond to IGF1 stimulation (Demonbreun et al.,
2010) and notably after exposure to IGF, the IGF1 receptor was
found in lysosomes in myoferlin null myoblasts. Dysferlin null
mice, a model for limb girdle muscular dystrophy, also do not
respond to IGF exposure (Demonbreun et al., 2010). We now show
that loss of EHD1 similarly disrupts recycling of transferrin and we
expect loss of EHD1 similarly disrupts receptors that mediate
growth in a variety of tissues including muscle. This may include
the IGF1 receptor, but given the profound developmental pheno-
type in EHD1 mice, this molecular defect likely extends to
implicate other receptors as well.
EHD1 is required for normal myogenesis
Muscle development can be modeled in cell culture where
cultured myoblasts can be induced to differentiate and fuse in
response to serum withdrawal. The formation of de novo
myotubes is a process that requires membrane and vesicle
trafﬁcking (Posey et al., 2011a). Myoblast fusion requires the
coalescence of two membranes. We found that cultured myoblasts
from EHD1-null mice were highly defective in myoblast fusion.
Fig. 8. EHD1 regulates BIN1 mediated tubule formation. (A) C2C12 myoblasts were transfected with wildtype EHD1-mCherry, EHD1T72A-mCherry, or BIN1-GFP. Cells were
ﬁxed twenty-four hours after transfection. (A) and (B) EHD1 and BIN1 normally form tubules in C2C12 myoblasts. Expression of EHD1T72A results in lack of tubule formation
and aggregation of EHD1T72A in the cytoplasm. High magniﬁcation images are shown in the lower right corner. (C) BIN1-GFP was transfected into C2C12 cells in
combination with EHD1-mCherry or EHD1T72A-mCherry. EHD1 and BIN1 together form an organized tubule network with discrete points of colocalization. The presence of
EHD1T72A results in smaller (0.51 mm compared to 0.662 mm tubules, p¼0.007) and more numerous BIN1-positive tubules (268 compared to 166 tubules per 20 mm2 area,
p¼0.04). The white dotted box highlights the area of the cell depicted in the magniﬁed image to the right. Scale bar 20 mm, 1.5 mm.
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These cells expressed desmin, a marker of cell speciﬁcation in the
early stages of myogenesis, so loss of EHD1 does not impair the
early phase of myoblast differentiation. Transcriptional control of
myogenesis is well established where muscle speciﬁc transcription
factors such as MyoD, Mef2, Myf5 and myogenin drive differentia-
tion (Hasty et al., 1993; Molkentin et al., 1995; Olson et al., 1995;
Rudnicki et al., 1993). We speculate that normal myoblast differ-
entiation requires cues from the cytoplasm and matrix to be fully
successful and this transmission requires normal vesicle
trafﬁcking.
The ferlins are found enriched at the plasma membrane, but
also within internal vesicles that may be associated with the
plasma membrane (Bansal et al., 2003; Doherty et al., 2005,
2008; Posey et al., 2011b). Myoferlin is enriched at the sites of
cell-cell fusion during myogenesis (Doherty et al., 2005). Intracel-
lular aggregation of the ferlins is expected to be associated with an
inhibition of normal function. Internalized ferlin staining patterns
have been observed in muscle biopsies from patients with varying
forms of muscle disease. However, the speciﬁcity and signiﬁcance
of this ﬁnding is not yet clear. In a form of centronuclear myopathy
caused by a mutation in dynamin-2, dysferlin is sequestered from
the plasma membrane and accumulates within the myoﬁber
(Durieux et al., 2010). We suggest that ferlin mislocalization
signiﬁcantly contributes to the growth defect in EHD1-null muscle.
Vesicle trafﬁcking in muscle
Loss of function mutations in dysferlin and caveolin-3, two
other proteins involved in vesicle trafﬁcking, cause muscular
dystrophy (Bashir et al., 1998; McNally et al., 1998). EHD1-null
muscle is not dystrophic, but rather is growth impaired, and this is
associated with grossly malformed T-tubules. Loss of dysferlin,
caveolin-3 or BIN1 causes vesicle accumulation and T-tubule
abnormalities within muscle (Galbiati et al., 2001; Klinge et al.,
2010; Toussaint et al., 2011). EHD1 lacks a transmembrane domain
and is thought to interact with protein components via its EH
domain. EHDs are associated with the cytoplasm and with actin
binding proteins. We propose a model in which the EHDs, in an
ATPase dependent manner, dynamically associate with ferlins,
caveolin-3, and BIN-1 proteins as well as with other interacting
partners during development at the T-tubule and at the sarco-
lemma allowing cytoplasmic rearrangements and vesicle mem-
brane fusion. This is consistent with the role of the EHD family of
proteins as an important regulator of intracellular trafﬁcking at
critical nodes of the endocytic recycling pathway like the Rab
family of GTPases (Naslavsky and Caplan, 2011). Muscle, with its
unique structure and development, is highly dependent on this
intracellular trafﬁcking.
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